I attend the American Society of Clinical Oncology (ASCO) meeting in Chicago in May. As usual, it was exciting and it provides me with a fantastic opportunity to catch up with the current research in advanced prostate cancer. It also gives me an opportunity to meet with and have private conversations with some of the [...]
When I went on my first round of hormone therapy (ADT) I experienced severe cognitive side effects. I found it impossible to concentrate, read and remember anything. I lost the ability to navigate the New York City subways no less drive my car to a destination. Occasionally, when I was attempting to navigate the subway [...]
To all of my American readers and anyone else who celebrates, I wish you a healthy and happy Thanksgiving. To those of you who do not celebrate Thanksgiving Day, I want to point out that it can still be a time that is important for all of us. It's always good to take time, take [...]
I recently read a very interesting post by Trisha Torrey on About.com about a happening on the TV show, Downton Abbey. Downton Abbey is a PBS (in the United States) TV show that originates from the UK. Briefly, the show is about the British aristocracy and their help, not dissimilar to the other famous show [...]
On June the 4th I reported on the SWOG-9346 study presented at the ASCO Meeting in Chicago (http://advancedprostatecancer.net/?p=3264). In the presentation by principal investigator, Maha Hussain, M.D., F.A.C.P., from the University of Michigan Comprehensive Cancer Center, Dr. Hussain reported that intermittent androgen-deprivation (IAD) therapy is not as good as continuous hormone therapy with regard to [...]